Open AccessP764: RESPONSE AND SURVIVAL OUTCOMES WITH HYPOMETHYLATING AGENTS IN AN ARGENTINEAN COHORT OF 113 PATIENTS WITH CHRONIC MYELOMONOCITIC LEUKEMIA
Author(s) -
Gonzalez J.,
Perusini A.,
Russo F.,
Fuentes L.,
Deluca T.,
Basquiera A. L.,
Navickas A.,
Kornblihtt L.,
Pintos N.,
Nucifora E.,
Iastrebner M.,
Enrico A.,
Arbelbide J.,
Belli C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845940.81565.29
Subject(s) - medicine , chronic myelomonocytic leukemia , retrospective cohort study , hazard ratio , proportional hazards model , cohort , hypomethylating agent , myelodysplastic syndromes , confidence interval , bone marrow , gene , biochemistry , chemistry , gene expression , dna methylation